Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect
Shouyi Wu,1 Yajun Lian,1 Haifeng Zhang,1 Yuan Chen,1 Chuanjie Wu,2 Shuang Li,1 Yake Zheng,1 Yuhan Wang,1 Wenchao Cheng,1 Zhi Huang11Department of Neurology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou City, Henan Province, People’s Republic of China; 2Department of Neuro...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-07-01
|
| Series: | Journal of Pain Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/botulinum-toxin-type-a-for-refractory-trigeminal-neuralgia-in-older-pa-peer-reviewed-article-JPR |
| _version_ | 1811222025997385728 |
|---|---|
| author | Wu S Lian Y Zhang H Chen Y Wu C Li S Zheng Y Wang Y Cheng W Huang Z |
| author_facet | Wu S Lian Y Zhang H Chen Y Wu C Li S Zheng Y Wang Y Cheng W Huang Z |
| author_sort | Wu S |
| collection | DOAJ |
| description | Shouyi Wu,1 Yajun Lian,1 Haifeng Zhang,1 Yuan Chen,1 Chuanjie Wu,2 Shuang Li,1 Yake Zheng,1 Yuhan Wang,1 Wenchao Cheng,1 Zhi Huang11Department of Neurology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou City, Henan Province, People’s Republic of China; 2Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of ChinaBackground: Some studies have indicated that a local injection of Botulinum Toxin Type A (BTX-A) is a promising therapy for trigeminal neuralgia (TN). However, BTX-A treatment is still ineffective for approximately 10–43% of patients. We therefore investigated which factors are associated with the therapeutic effect in BTX-A treatment of medically refractory, classical TN.Methods: We performed a retrospective cohort study with a total of 104 patients who were receiving BTX-A injection for medically refractory classical TN between August 2013 and October 2016. A VAS score, pain attack frequency per day as well as patients’ overall response to treatment and side effects were evaluated in 104 patients with TN who were receiving BTX-A.Results: A total of 87 patients reported successful results; 41 stated that their pain was completely controlled while 46 reported adequate pain relief, totaling 83.7%. Our study suggests that treatment success was higher in patients 50 or older (OR=3.66, 95% CI: 1.231–10.885). Univariate and multivariate analyses demonstrated that the patient’s age was independently associated with treatment outcome (OR=1.72, 95% CI: 1.063–2.282), with ≥50 years being a significant predictor of pain relief (P=0.020 and P=0.033, respectively). Seventeen patients (16.3%) reported mild side effects.Conclusion: A local injection of BTX-A may be a safe and efficient treatment for classical TN which lasts for several months. BTX-A is a novel strategy which is particularly worth trying for particularly middle-aged and elderly patients who cannot tolerate drug side effects and may be afraid of serious complications from microvascular decompression.Keywords: trigeminal neuralgia, Botulinum Toxin Type A, age, local injection, therapeutic effect |
| first_indexed | 2024-04-12T08:08:26Z |
| format | Article |
| id | doaj.art-fb1b1624a20e49ab865b561eb1b245bc |
| institution | Directory Open Access Journal |
| issn | 1178-7090 |
| language | English |
| last_indexed | 2024-04-12T08:08:26Z |
| publishDate | 2019-07-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Journal of Pain Research |
| spelling | doaj.art-fb1b1624a20e49ab865b561eb1b245bc2022-12-22T03:41:03ZengDove Medical PressJournal of Pain Research1178-70902019-07-01Volume 122177218647209Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effectWu SLian YZhang HChen YWu CLi SZheng YWang YCheng WHuang ZShouyi Wu,1 Yajun Lian,1 Haifeng Zhang,1 Yuan Chen,1 Chuanjie Wu,2 Shuang Li,1 Yake Zheng,1 Yuhan Wang,1 Wenchao Cheng,1 Zhi Huang11Department of Neurology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou City, Henan Province, People’s Republic of China; 2Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of ChinaBackground: Some studies have indicated that a local injection of Botulinum Toxin Type A (BTX-A) is a promising therapy for trigeminal neuralgia (TN). However, BTX-A treatment is still ineffective for approximately 10–43% of patients. We therefore investigated which factors are associated with the therapeutic effect in BTX-A treatment of medically refractory, classical TN.Methods: We performed a retrospective cohort study with a total of 104 patients who were receiving BTX-A injection for medically refractory classical TN between August 2013 and October 2016. A VAS score, pain attack frequency per day as well as patients’ overall response to treatment and side effects were evaluated in 104 patients with TN who were receiving BTX-A.Results: A total of 87 patients reported successful results; 41 stated that their pain was completely controlled while 46 reported adequate pain relief, totaling 83.7%. Our study suggests that treatment success was higher in patients 50 or older (OR=3.66, 95% CI: 1.231–10.885). Univariate and multivariate analyses demonstrated that the patient’s age was independently associated with treatment outcome (OR=1.72, 95% CI: 1.063–2.282), with ≥50 years being a significant predictor of pain relief (P=0.020 and P=0.033, respectively). Seventeen patients (16.3%) reported mild side effects.Conclusion: A local injection of BTX-A may be a safe and efficient treatment for classical TN which lasts for several months. BTX-A is a novel strategy which is particularly worth trying for particularly middle-aged and elderly patients who cannot tolerate drug side effects and may be afraid of serious complications from microvascular decompression.Keywords: trigeminal neuralgia, Botulinum Toxin Type A, age, local injection, therapeutic effecthttps://www.dovepress.com/botulinum-toxin-type-a-for-refractory-trigeminal-neuralgia-in-older-pa-peer-reviewed-article-JPRTrigeminal neuralgiaBotulinum toxin AAgeLocal injectionTherapeutic effect |
| spellingShingle | Wu S Lian Y Zhang H Chen Y Wu C Li S Zheng Y Wang Y Cheng W Huang Z Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect Journal of Pain Research Trigeminal neuralgia Botulinum toxin A Age Local injection Therapeutic effect |
| title | Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect |
| title_full | Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect |
| title_fullStr | Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect |
| title_full_unstemmed | Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect |
| title_short | Botulinum Toxin Type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect |
| title_sort | botulinum toxin type a for refractory trigeminal neuralgia in older patients a better therapeutic effect |
| topic | Trigeminal neuralgia Botulinum toxin A Age Local injection Therapeutic effect |
| url | https://www.dovepress.com/botulinum-toxin-type-a-for-refractory-trigeminal-neuralgia-in-older-pa-peer-reviewed-article-JPR |
| work_keys_str_mv | AT wus botulinumtoxintypeaforrefractorytrigeminalneuralgiainolderpatientsabettertherapeuticeffect AT liany botulinumtoxintypeaforrefractorytrigeminalneuralgiainolderpatientsabettertherapeuticeffect AT zhangh botulinumtoxintypeaforrefractorytrigeminalneuralgiainolderpatientsabettertherapeuticeffect AT cheny botulinumtoxintypeaforrefractorytrigeminalneuralgiainolderpatientsabettertherapeuticeffect AT wuc botulinumtoxintypeaforrefractorytrigeminalneuralgiainolderpatientsabettertherapeuticeffect AT lis botulinumtoxintypeaforrefractorytrigeminalneuralgiainolderpatientsabettertherapeuticeffect AT zhengy botulinumtoxintypeaforrefractorytrigeminalneuralgiainolderpatientsabettertherapeuticeffect AT wangy botulinumtoxintypeaforrefractorytrigeminalneuralgiainolderpatientsabettertherapeuticeffect AT chengw botulinumtoxintypeaforrefractorytrigeminalneuralgiainolderpatientsabettertherapeuticeffect AT huangz botulinumtoxintypeaforrefractorytrigeminalneuralgiainolderpatientsabettertherapeuticeffect |